Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
Common Symptoms You May Notice According to a clinical study, women report more severe symptoms during the winter months than in other seasons, which is attributed to reduced sunlight exposure and lower vitamin D levels
Some medications can lower carnitine levels
Jafarzadeh A, Nemati M, Khorramdelazad H, Hassan ZM
US$ 28.52
US$ 22.02
US$ 21.34
US$ 29.67
US$ 22.80
US$ 26.94
US$ 28.24
